Biologics Orthobiologics Market | Exclusive Report on the Latest Revenue and Future Scope – MDC Research byChris StewartMarch 31, 2022
Biologics Spine SeaSpine® Announces Full Commercial Launch of NorthStar™ Facet Fusion and Limited Commercial Launch of FLASH™ Navigation Lumbar Facet Fusion byChris StewartMarch 2, 2022
Biologics Regulatory Kuros Biosciences Further Strengthens Orthobiologics Patent Portfolio byJosh SandbergJuly 23, 2020
Biologics Financial Orthobiologics Market for Bone Repair & Regeneration, 2018-2024 – Dominated by Medtronic, MTF Biologics, NuVasive, and Orthofix byJosh SandbergApril 16, 2020
Biologics Acumed Signs Agreement with Vivorte to Distribute its Orthobiologics Portfolio byJosh SandbergMarch 13, 2020
Biologics Financial Orthobiologics Market Worth 6.06 Billion USD by 2022 byJosh SandbergSeptember 27, 2017
Biologics Recon Bioventus Launches SUPARTX FX™ Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis byJosh SandbergOctober 13, 2015
Biologics CollPlant Executes Non-binding Term Sheet to Develop and Commercialize a Novel Product for Spinal Fusion and Trauma Indications in Collaboration with Leading US Partner byJosh SandbergJuly 14, 2015
